Streetbeat News

Stock Prices

WMT

Walmart Inc. (NYSE:WMT) is experiencing a potential breakout, which could lead to a new uptrend. Breakouts occur when a stock surpasses a resistance level, indicating a bullish trend. Walmart's resistance has been around $77.30, and surpassing this could lead to higher prices as sellers are cleared out.

Portfolio Pulse from Mark Putrino

September 10, 2024 | 4:07 pm

AILE

iLearningEngines shares rose following a response from the company's CEO to short seller statements.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 4:05 pm

BRX

In the past three months, 12 analysts have provided ratings for Brixmor Property Group (NYSE:BRX), with a mix of bullish and indifferent sentiments. The average 12-month price target has increased by 10.21% to $28.38. Analysts have raised their price targets, reflecting a positive outlook despite the company's below-average financial metrics compared to industry peers.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:01 pm

DVN

Deep-pocketed investors are showing a bearish sentiment towards Devon Energy (NYSE:DVN) through significant options activity. The majority of these investors are betting on a price range between $35.0 and $57.5. Despite a recent price drop, analysts have mixed ratings with an average target price of $58.0.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:01 pm

OSCR

Oscar Health (NYSE:OSCR) has received recent analyst ratings, all of which are somewhat bullish. The average 12-month price target is $26.5, reflecting a slight increase from previous targets. Oscar Health has shown significant revenue growth but lags behind industry peers in net margin. The company demonstrates strong financial management with a high ROE and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

MA

Investors are showing significant interest in Mastercard options, with a mix of bullish and bearish trades. The options activity suggests a price range of $440 to $550 for Mastercard. Analysts have mixed ratings, with price targets ranging from $520 to $570.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

JBI

In the past three months, analysts have shown a mixed outlook on Janus Intl Gr (NYSE:JBI), with recent ratings indicating a downward trend in price targets. The average 12-month price target is now $13.25, down from $16.88. Analysts have lowered their ratings and price targets due to market conditions and company performance. Despite challenges like a decline in revenue growth, Janus Intl Gr maintains strong profitability with a high net margin and ROE.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

CVS

Analysts have mixed views on CVS Health, with recent ratings showing a majority as indifferent. The average 12-month price target is $62.33, slightly down from previous estimates. CVS Health's financial metrics indicate challenges in profitability and asset utilization, despite strong market capitalization and revenue growth.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

INSM

Insmed (NASDAQ:INSM) has significantly outperformed the market over the past decade, with an annualized return of 18.36%. A $1000 investment in Insmed 10 years ago would now be worth $5,347.05, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

PODD

Insulet (NASDAQ:PODD) has significantly outperformed the market over the past 15 years, with an average annual return of 22.2%. A $1000 investment in Insulet 15 years ago would now be worth $20,354.17. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm